New York, NY · Founded 2024 · Privately Held (backing)
Developer of a cell restoration technology designed to enable longevity. HeXembio is based in New York, NY and was founded in 2024. Its last reported valuation was $25 million in Mar 2025. It has raised $19.8 million.
Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$19.8M
Last round
—
Cap table — not yet on record
HeXembio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HeXembio with a free account
·The complete investor list: 23 names
·Watch HeXembio: the Monday email on marks, rounds and moves
